MetaCap

Fate Therapeutics (FATE) Stock Chart

NASDAQ: FATEHealthcareBiotechnologyUSD

2.15-0.14 (-6.11%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

FATE technical summary

FATE is trading 13.0% below its 50-day simple moving average of $2.47 and 15.0% above its 200-day average of $1.87. The 50-day average is above the 200-day average, a configuration technical analysts associate with a longer-term uptrend. The 14-day Relative Strength Index (RSI) is 35.9, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $0.95 (Nov 14, 2025) to $3.23 (Jul 13, 2026); the current price sits 53% of the way from the low to the high. Annualized 30-day volatility is 46.3%. Based on the last session's high, low and close, the classic pivot point is $2.20, with first resistance at $2.25 and first support at $2.09.

These indicators describe past price behavior for Fate Therapeutics; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
3.23 (Jul 13)
1Y low
0.95 (Nov 14)
Last close
2.15

FATE price performance

1 week

-9.28%

1 month

-14.00%

3 months

-26.62%

6 months

+82.20%

Year to date

+119.39%

1 year

+54.68%

3 years

+26.47%

5 years

-96.49%

FATE price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day2.30Price below2.28Price below
10-day2.33Price below2.33Price below
20-day2.38Price below2.37Price below
50-day2.47Price below2.42Price below
100-day2.43Price below2.31Price below
200-day1.87Price above1.92Price above

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)2.41
Resistance 2 (R2)2.36
Resistance 1 (R1)2.25
Pivot point2.20
Support 1 (S1)2.09
Support 2 (S2)2.04
Support 3 (S3)1.93

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis